Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceuticals, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.
Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceuticals, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.
Talanta. 2023 Aug 1;260:124645. doi: 10.1016/j.talanta.2023.124645. Epub 2023 May 3.
Nucleic acid amplification techniques have always been one of the hot spots of research, especially in the outbreak of COVID-19. From the initial polymerase chain reaction (PCR) to the current popular isothermal amplification, each new amplification techniques provides new ideas and methods for nucleic acid detection. However, limited by thermostable DNA polymerase and expensive thermal cycler, PCR is difficult to achieve point of care testing (POCT). Although isothermal amplification techniques overcome the defects of temperature control, single isothermal amplification is also limited by false positives, nucleic acid sequence compatibility, and signal amplification capability to some extent. Fortunately, efforts to integrating different enzymes or amplification techniques that enable to achieve intercatalyst communication and cascaded biotransformations may overcome the corner of single isothermal amplification. In this review, we systematically summarized the design fundamentals, signal generation, evolution, and application of cascade amplification. More importantly, the challenges and trends of cascade amplification were discussed in depth.
核酸扩增技术一直是研究的热点之一,尤其是在 COVID-19 爆发期间。从最初的聚合酶链反应(PCR)到当前流行的等温扩增,每一种新的扩增技术都为核酸检测提供了新的思路和方法。然而,受耐热 DNA 聚合酶和昂贵的热循环仪的限制,PCR 难以实现即时检测(POCT)。尽管等温扩增技术克服了温度控制的缺陷,但单一的等温扩增在某种程度上也受到假阳性、核酸序列兼容性和信号放大能力的限制。幸运的是,整合不同酶或扩增技术的努力可以实现催化剂间的通讯和级联生物转化,从而克服单一等温扩增的局限性。在这篇综述中,我们系统地总结了级联扩增的设计基础、信号产生、演变和应用。更重要的是,深入讨论了级联扩增面临的挑战和趋势。